Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition

被引:320
作者
Maeda, M
Johnson, KR
Wheelock, MJ
机构
[1] Univ Nebraska, Med Ctr, Dept Oral Biol, Coll Dent, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
[3] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA
[4] Univ Nebraska, Med Ctr, Coll Med, Dept Pathol & Microbiol, Omaha, NE 68198 USA
[5] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
[6] Univ Nebraska, Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA
关键词
cadherin; TGF-beta; epithelium-to-mesenchyme transition; motility;
D O I
10.1242/jcs.01634
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epithelium-to-mesenchyme transitions (EMTs) are characterized by morphological and behavioral changes in cells. During an EMT, E-cadherin is downregulated while N-cadherin is upregulated. The goal of this study was to understand the role cadherin switching plays in EMT using a classical model system: transforming growth factor Pi (TGF-beta 1)-mediated EMT in mammary epithelial cells. We showed that stress fibers and focal adhesions are increased, and cell-cell junctions are decreased in response to TGF-beta 1. Moreover, these changes were reversible upon removal of TGF- I. Downregulation of E-cadherin and upregulation of N-cadherin were both transcriptional. Neither experimental knockdown nor experimental overexpression of N-cadherin interfered with the morphological changes. In addition, the morphological changes associated with EMT preceded the downregulation of E-cadherin. Interestingly, TGF-beta 1-induced motility in N-cadherin-knockdown cells was significantly reduced. Together, these data suggest that cadherin switching is necessary for increased motility but is not required for the morphological changes that accompany EMT.
引用
收藏
页码:873 / 887
页数:15
相关论文
共 80 条
[1]   Tube or not tube: Remodeling epithelial tissues by branching morphogenesis [J].
Affolter, M ;
Bellusci, S ;
Itoh, N ;
Shilo, B ;
Thiery, JP ;
Werb, Z .
DEVELOPMENTAL CELL, 2003, 4 (01) :11-18
[2]   TGF-β signaling in cancer -: a double-edged sword [J].
Akhurst, RJ ;
Derynck, R .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S44-S51
[3]   Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration [J].
Bakin, AV ;
Tomlinson, AK ;
Bhowmick, NA ;
Moses, HL ;
Arteaga, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36803-36810
[4]   The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells [J].
Batlle, E ;
Sancho, E ;
Franci, C ;
Domínguez, D ;
Monfar, M ;
Baulida, J ;
de Herreros, AG .
NATURE CELL BIOLOGY, 2000, 2 (02) :84-89
[5]   Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism [J].
Bhowmick, NA ;
Ghiassi, M ;
Bakin, A ;
Aakre, M ;
Lundquist, CA ;
Engel, ME ;
Arteaga, CL ;
Moses, HL .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (01) :27-36
[6]   The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors [J].
Bolós, V ;
Peinado, H ;
Pérez-Moreno, MA ;
Fraga, MF ;
Esteller, M ;
Cano, A .
JOURNAL OF CELL SCIENCE, 2003, 116 (03) :499-511
[7]   Induction and regulation of epithelial-mesenchymal transitions [J].
Boyer, B ;
Vallés, AM ;
Edme, N .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1091-1099
[8]   Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment [J].
Brabletz, T ;
Jung, A ;
Reu, S ;
Porzner, M ;
Hlubek, F ;
Kunz-Schughart, LA ;
Knuechel, R ;
Kirchner, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10356-10361
[9]  
Brattain Michael G., 1996, Current Opinion in Oncology, V8, P49, DOI 10.1097/00001622-199601000-00009
[10]   Loss-of-function mutations in SIP1 Smad interacting protein 1 result in a syndromic Hirschsprung disease [J].
Cacheux, V ;
Dastot-Le Moal, F ;
Kääriäinen, H ;
Bondurand, N ;
Rintala, R ;
Boissier, B ;
Wilson, M ;
Mowat, D ;
Goossens, M .
HUMAN MOLECULAR GENETICS, 2001, 10 (14) :1503-1510